Evidence map›Paper›PMID 18268092›Full record

ArticleBlood2008

The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia.

Zsuzsanna E Toth, Ronen R Leker, Tal Shahar, Sandra Pastorino, Ildiko Szalayova, Brook Asemenew, Sharon Key, Alissa Parmelee, Balazs Mayer, Krisztian Nemeth and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Colony-Stimulating Factors on Mobilizing CD34Frontiers in pharmacology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2015
    Article
  15. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Zsuzsanna E TothNational Institute of Dental and Craniofacial Research, Bethesda, MD 20892, USA.
Ronen R Leker
Tal Shahar
Sandra Pastorino
Ildiko Szalayova
Brook Asemenew
Sharon Key
Alissa Parmelee
Balazs Mayer
Krisztian Nemeth
Andras Bratincsák
Eva Mezey
National Institute of Dental and Craniofacial Research · USNational Institute of Neurological Disorders and Stroke · USNational Cancer Institute · USNational Institute of Mental Health · US

Funding

Contribution of bone marrow cells to tissue regeneration, immune function and hematopoiesisZIADE000714 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MEZEY, EVA M. · 2009 to 2025
$25.3M
Contribution of circulating bone marrow cells to tissueZ01DE000714 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MEZEY, EVA M. · 2005 to 2008
$1.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) induces proliferation of bone marrow-derived cells. G-CSF is neuroprotective after experimental brain injury, but the mechanisms involved remain unclear. Stem cell factor (SCF) is a cytokine important for the survival and differentiation of hematopoietic stem cells. Its receptor (c-kit or CD117) is present in some endothelial cells. We aimed to determine whether the combination of G-CSF/SCF induces angiogenesis in the central nervous system by promoting entry of endothelial precursors into the injured brain and causing them to proliferate there. We induced permanent middle cerebral artery occlusion in female mice that previously underwent sex-mismatched bone marrow transplantation from enhanced green fluorescent protein (EGFP)-expressing mice. G-CSF/SCF treatment reduced infarct volumes by more than 50% and resulted in a 1.5-fold increase in vessel formation in mice with stroke, a large percentage of which contain endothelial cells of bone marrow origin. Most cells entering the brain maintained their bone marrow identity and did not transdifferentiate into neural cells. G-CSF/SCF treatment also led to a 2-fold increase in the number of newborn cells in the ischemic hemisphere. These findings suggest that G-CSF/SCF treatment might help recovery through induction of bone marrow-derived angiogenesis, thus improving neuronal survival and functional outcome.

Indexed as

Bone Marrow TransplantationAnimalsBrain IschemiaCell DivisionDrug Therapy, CombinationEndothelial CellsFemaleGranulocyte Colony-Stimulating FactorGreen Fluorescent ProteinsInfarction, Middle Cerebral ArteryMiceMice, Inbred C57BLNeovascularization, PhysiologicRecovery of FunctionStem Cell FactorGranulocyte Colony-Stimulating FactorGreen Fluorescent ProteinsStem Cell Factor

Identifiers

PMID18268092
PMCPMC2424152
OpenAlexW2063238938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.